Few treatments exist today beyond powerful steroids to knock down a patient's immune ... of the patients' mutations were published in the Journal of Experimental Medicine. Autoimmune diseases, which ...

IGM Biosciences Inc.’s stock tumbled 14% Tuesday, as analysts weighed in with dismay on the company’s pivot away from ...

Evio Pharmacy Solutions, a Blues-founded company focused on transformational solutions in the high-cost medication space, today announced the successful negotiation and implementation of an innovative ...

In Czechia, over 160,000 people and approximately 4,000 children are living with rheumatoid arthritis. While modern medicine ...

Could the adoption of cutting-edge imaging technologies and innovative use of existing methods revolutionize the diagnosis ...

Juvenile idiopathic arthritis symptoms may only affect certain joints. Some children have systemic reactions, such as rash.

A groundbreaking study led by scientists from the University of Colorado has uncovered a potential trigger for rheumatoid ...

Rituximab and ocrelizumab, two drugs often used to treat multiple sclerosis (MS), may be useless for people with th ...

Hip arthritis presents in several forms such as osteoarthritis, rheumatoid arthritis, and avascular necrosis, each with ...

In people with primary progressive multiple sclerosis (MS), a new study has found no difference in the amount of time before ...

AbbVie (NYSE: ABBV) today announced positive results from a new post-hoc analysis from the Measure Up 1 and Measure Up 2 Phase 3 studies. The analysis evaluated the efficacy of upadacitinib (15 mg or ...